Use the Back button in your browser to see the other results of your search or to select another record.

Detailed Search Results

Comparative effectiveness of Chuna manipulative therapy for non-acute lower back pain: a multi-center, pragmatic, randomized controlled trial
Park S-Y, Hwang E-H, Cho J-H, Kim K-W, Ha I-H, Kim M-R, Nam K, Lee M-H, Lee J-H, Kim N, Shin B-C
Journal of Clinical Medicine 2020 Jan;9(1):144
clinical trial
8/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: Yes; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: Yes; Adequate follow-up: Yes; Intention-to-treat analysis: Yes; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed*

Current evidence on the effectiveness and safety of Chuna manipulative therapy (CMT) for managing non-acute lower back pain (LBP) is insufficient. We investigated the comparative effectiveness and safety of CMT, a Korean style of manipulation, plus usual care (UC) compared to UC alone for non-acute LBP. We conducted a parallel, two-armed, multi-centered, assessor blinded, pragmatic, randomized controlled trial at four major Korean medical hospitals. Overall, 194 patients were randomly allocated to either CMT+UC (n = 97) or UC alone (n = 97), for six weeks of treatment and six months follow-up. The primary outcome was measured using the numerical rating scale (NRS) of LBP intensity at 7 weeks. Secondary outcomes included NRS of leg pain, Oswestry Disability Index (ODI) for functional disability, patient global impression of change (PGIC) scale, and safety. A total of 194 patients were included in the intention-to-treat analysis, and 174 patients provided complete data for the primary outcome. At 7 weeks, clinically significant differences between groups were observed in the NRS of LBP (CMT+UC -3.02 +/- 1.72, UC -1.36 +/- 1.75, p < 0.001), ODI scores (CMT+UC -5.65 +/- 4.29, UC -3.72 +/- 4.63, p = 0.003), NRS of leg pain (CMT+UC -2.00 +/- 2.33, UC -0.44 +/- 1.86, p < 0.0001), and PGIC (CMT+UC -0.28 +/- 0.85, UC 0.01 +/- 0.66, p = 0.0119). Mild to moderate safety concerns were reported in 21 subjects. CMT+UC showed higher effectiveness compared to UC alone in patients with non-acute LBP in reducing LBP and leg pain and in improving function with good safety results using a powered sample size and including mid-term follow-up.

Full text (sometimes free) may be available at these link(s):      help